Major Novartis Shareholder Calls for Board Overhaul After Record Share Decline
Source Summary
A major Novartis shareholder has called for a board shake-up following the company's shares experiencing a record decline. The share fall was triggered by trial setbacks affecting the drugmaker.
Why it matters
Shareholder activism targeting board composition signals investor concern about management's ability to navigate clinical and commercial challenges at a major pharmaceutical company.
